Three Important Drug Safety Updates — 10 September 2026
- 10-09-2026
- Posted by: Eldaniz Hasanov
- Category: Regulatory Updates
No Comments
Today’s pharmacovigilance monitoring identified three important updates.
- ANSM — meningioma risk with desogestrel/etonogestrel. Read more on ANSM
- ANSM — fluoropyrimidine safety (capecitabine and 5‑FU). Read more on ANSM
- NMPA No. 87/2026 — change to the instruction for inosine injection. Official NMPA notice